FRAGMIN 18000 UNIT / 0.72 ML
DALTEPARIN SODIUM : 18000 UNIT / 0.72 ML · DIN 02352680 · PFIZER CANADA ULC
Health Canada status: MARKETED
What is FRAGMIN?
FRAGMIN 18000 UNIT / 0.72 ML contains DALTEPARIN SODIUM : 18000 UNIT / 0.72 ML. It is listed in the Health Canada Drug Product Database under DIN 02352680, held by PFIZER CANADA ULC, supplied as SOLUTION for INTRAVENOUS ; SUBCUTANEOUS administration. Health Canada currently lists it as marketed, status dated 01-Feb-2011. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is FRAGMIN used for?
Fragmin (dalteparin sodium injection) is indicated for: • Thromboprophylaxis in conjunction with surgery • Treatment of acute deep venous thrombosis • Unstable coronary artery disease (UCAD), i.e., unstable angina and non - Q - wave myocardial infarction • Prevention of clotting in the extracorporeal system during hemodialysis and hemofiltration in connection with acute renal failure or chronic renal insufficiency • Extended treatment of symptomatic venous thromboembolism (VTE) to prevent recurrence of venous thromboembolism in patients with cancer • Reduction of deep vein thrombosis (DVT) in hospitalized patients with severely restricted mobility during acute illness.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02352680 |
|---|---|
| Brand name | FRAGMIN |
| Generic / active ingredient | DALTEPARIN SODIUM : 18000 UNIT / 0.72 ML |
| Manufacturer | PFIZER CANADA ULC |
| Strength | 18000 UNIT / 0.72 ML |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS ; SUBCUTANEOUS |
| Schedule | Prescription |
| ATC code | B01AB04 DALTEPARIN |
| AHFS class | 20:12.04.16 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 01-Feb-2011 |
| Original market date | 2011-02-01 00:00:00 |
How is it stored and handled?
null
How is it supplied?
Solution for injection, 25 000 IU (anti - factor Xa)/mL, 3.8 mL multi - dose vial, package of 1. Solution for injection, 2 500 IU (anti - factor Xa)/0.2 mL, single dose 0.5 mL syringe*, package of 10. Solution for injection, 3 500 IU (anti - factor Xa)/0.28 mL, single dose 0.5 mL syringe*, package of 10. Solution for injection, 5 000 IU (anti - factor Xa)/0.2 mL, single dose 0.5 mL syringe*, package of 10. Solution for injection, 7 500 IU (anti - factor Xa)/0.3 mL, single dose 0.5 mL syringe*, package of 5. Solution for injection, 10 000 IU (anti - factor Xa)/0.4 mL, single dose 1 mL syringe*, package of 5. Solution for injection, 12 500 IU (anti - factor Xa)/0.5 mL, single dose 1 mL syringe*, package of 5. Solution for injection, 15 000 IU (anti - factor Xa)/0.6 mL, single dose 1 mL syringe*, package of 5. Solution for injection, 16 500 IU (anti - factor Xa)/0.66 mL, single dose 1 mL syringe*, package of 5. Solution for injection, 18 000 IU (anti - factor Xa)/0.72 mL, single dose 1 mL syringe*, package of 5.
What can be used instead?
Other Canadian products sharing ATC code B01AB04 DALTEPARIN. 10 of 13 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FRAGMIN | 10000 UNIT / 0.4 ML | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02352656 |
| FRAGMIN | 12500 UNIT / 0.5 ML | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02352664 |
| FRAGMIN | 15000 UNIT / 0.6 ML | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02352672 |
| FRAGMIN | 16500 UNIT / 0.66 ML | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02494582 |
| FRAGMIN | 2500 UNIT / 0.2 ML | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02132621 |
| FRAGMIN | 25000 UNIT | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02231171 |
| FRAGMIN | 3500 UNIT / 0.28 ML | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02430789 |
| FRAGMIN | 5000 UNIT / 0.2 ML | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02132648 |
| FRAGMIN | 7500 UNIT / 0.3 ML | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02352648 |
| FRAGMIN | 10000 UNIT | SOLUTION | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 02132664 |
Who else supplies DALTEPARIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DALTEPARIN appears in 32 registered pack listings across 4 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.